Engineering novel biosensors for unmet needs
Helping couples grow a family by allowing women to assess their fertility health
Providing farmers a tool to manage their herd and time animal reproduction
Evaluating the health of our environment to revitalize fragile ecosystems
BioSens8 was accepted into the Nucleate accelerator 2022 cohort! We'll be working through Spring engaging with clinical and business mentors to grow our company.
BioSens8 is participating as a host company in Brown University's PRIME graduate program in order to discover potential markets we can enter with our IP.
BioSens8 engaged in NSF's Beat the Odds Bootcamp in order to complete even further customer discovery in the human fertility market segment.
BioSens8 is participating as a host company in the Boston University Questrom business school class, Bench to Bedside, to discover potential markets our platform technology can be applied toward and then follow with customer discovery!
BioSens8 is participating as a host company in the MIT Sloan business school class, E-Lab, to diver deeper into unmet needs and identify the value propositions of our progesterone biosensor in the FemTech space!
NSF has awarded our STTR Phase I proposal for developing a novel progesterone biosensor for monitoring fertility health! We're delighted to have the support of NSF, the funds will be used for achieving technical milestones required for commercialization.
BioSens8 was selected from more than 3000 global applicants to join the MassChallenge 2021 cohort! We're excited to partake alongside 228 other startups!
Boston University has awarded Dr. James Galagan with the Ignition Award! The funds will be used for R&D work toward bringing a novel animal healthcare biosensor to market.
BioSens8 was awarded the second largest prize at the M2D2 $200K Challenge! We're thrilled to be supported by M2D2 with a cash award! Check out our award winning pitch.
BioSens8 pitched in front of a panel of Med Tech judges including industry leaders, investors, and practitioners for the BU Ignition Award.
BioSens8 was selected as a M2D2 $200K Finalist! We were one of 15 startups (out of more than 170 worldwide entrants) in the running for $200,000 in in-kind services and research support from sponsors that include UMass Lowell, Amgen, Boston Scientific, Johnson & Johnson Innovation, Massachusetts Life Sciences Center, Mintz, and others.
BioSens8 successfully submitted a NSF STTR Phase I application.
BioSens8 was selected as a Boston University Ignition Award finalist! Our full proposal was well received by the Ignition Review Committee, made up of outside representatives (investors, industry) and BU academics. As a finalist, BioSens8 will present for the Ignition Award on 4/7/2021.
BioSens8 officially incorporated.
BioSens8 was selected to submit a full proposal for the Boston University Ignition Award! The Ignition Award program is designed to help Boston University researchers bring their projects with commercial potential to the next level.
BioSens8 was accepted to partake in the NSF NE I-Corps Spark Program to perform customer discovery!
If you wish to invest, become a business partner, license our technology or require a biosensor solution
please contact: firstname.lastname@example.org